8 Weeks Versus 12 Weeks of Elbasvir/Grazoprevir in Treatment-naïve CHC With Mild Fibrosis
NCT03186365
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
82
Enrollment
OTHER
Sponsor class
Conditions
Hepatitis C, Chronic
Interventions
DRUG:
Zepatier Oral Product
Sponsor
Kaohsiung Medical University Chung-Ho Memorial Hospital